Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
The Netherlands Journal of Medicine|August 1, 1993
Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five casesR A de Man, H J Metselaar, R A Heijtink, et al.
Journal of Medical Virology|February 1, 1989
Long-term immune reactivity to pre-S(2)-antigen after acute hepatitis B infectionR A Heijtink, G A de Wilde, J van Hattum, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1990
Recurrence and survival after abdominoperineal and low anterior resection for rectal cancer, without adjunctive therapyT E Fick, C G Baeten, M F von Meyenfeldt, et al.
Hepatology (Baltimore, Md.)|January 1, 1986
Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhageA L Boks, E J Brommer, S W Schalm, et al.
Antiviral Research|November 26, 2003
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutionsE H C J Buster, A A van der Eijk, S W Schalm
Clinical Therapeutics|January 25, 2000
Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infectionT G van Rossum, A G Vulto, W C Hop, et al.
Bailliere'S Best Practice & Research. Clinical Gastroenterology|September 8, 2000
Management of osteoporosis in primary biliary cirrhosisF H Wolfhagen, H R van Buuren, F P Vleggaar, et al.
Journal of Hepatology|January 6, 2000
New treatment strategies in non-responder patients with chronic hepatitis CS W Schalm, J T Brouwer, F C Bekkering, et al.
The American Journal of Gastroenterology|August 22, 2001
Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis CT G van Rossum, A G Vulto, W C Hop, et al.
Antiviral Research|May 20, 1999
Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?L M Wolters, H G Niesters, R A de Man, et al.
Pageof 27